Pharmafile Logo

Poisson Rouge

Poisson Rouge is a London based company that specialises in producing unique and high impact teambuilding activities, people development programmes and event management services. For nearly 20 years we have been combining our passion and creativity to create some of the most unusual, fun, and exciting team events and some of the most innovative ways to develop people available anywhere on Earth. However, instead of wanging on about how great we think we are we thought we’d just let our unique ideas, our long track record of success and our clients do the talking!

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

96 west yard, Camden Lock Place, London, N6 6BL, United Kingdom
+44 (0)20 7267 3646

 Latest Content from PMHub 

Genesis Research Group RWD / HTA / regulatory / ECA webinar on 15 Feb: reserve your place!

On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar...

Clinical trials explained: Why iconography matters…

Press Releases | January 17, 2024 | Cuttsy + Cuttsy

Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Unlock possibilities: A Medical Affairs strategy fit for the future

Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.

Why Words Matter: Person-first language in the age of identity

White Papers and Resources | January 12, 2024 | Mednet

We take a look at why the words we use in medcomms matter and examine the use of patient-first language

Advancing digital engagement in pharma and healthcare: 2024 focus areas

Press Releases | January 12, 2024 | Graphite Digital

6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Cuttsy+Cuttsy appoints Harriet Karia as Managing Director

Press Releases | January 4, 2024 | Cuttsy + Cuttsy

Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.